Leica Bond Rx Controller
Description
This is a Firm Fixed Price Purchase Order. The National Cancer Institute (NCI) awarded a purchase order to Ferox LLC to obtain a Bond Rx Controller for a clinical instrument (Leica Bond) Automated Immunohistochemistry stainer annual (1 year warranty included) and recommended Preventative Maintenance post-instrument relocation (with PM Kit included). The instrument will be used for validation of clinical IHC target markers for diagnostic and in some cases enrollment to NIH clinical trials. In the clinical research application, the Bond Rx instrument will be used for critical research in rare tumor identification and subsequent development of therapeutic mechanisms for patients undergoing treatments.
The rest of this notice
The tender documents, the buyer's named contact and the award history for this notice are free. Create an account to open the full record.
- Download the tender documents
- Contact the buyer directly
- See who won, and for how much
- Get alerts for tenders like this one
Free — no card, no trial clock.
Guides for bidders
New to public sector tendering? These short guides explain how the process works.